KL and metabolic dysfunction-associated steatotic liver disease: Interestingly, subgroup analyses further revealed that patients with liver disease played an enhancing role, and previous studies have also found α-Klotho to be elevated in patients with cirrhosis and non-alcoholic fatty liver disease-related fibrosis (53, 54).